Welcome to our dedicated page for Aveanna Healthcare Holdings SEC filings (Ticker: AVAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aveanna Healthcare Holdings Inc. filings document the public-company disclosures of a home healthcare operator with pediatric and adult care services. Its 8-K reports cover operating and financial results, guidance updates, Regulation FD investor presentations, material-event disclosures, capital-structure matters, and material agreements tied to the company and its common stock.
Proxy and governance filings describe annual meeting matters, board composition, committee service, executive compensation arrangements, employment agreements, stock incentive plan matters, and stockholders agreement provisions, including transfer restrictions and ownership-guideline-related terms. The filing record also includes director transitions and governance disclosures connected to compensation, nominating and corporate governance, and clinical quality and compliance oversight.
Aveanna Healthcare Holdings, Inc. (AVAH) received a Form 144 notice indicating that director Erica G. Schwartz intends to sell up to 230,343 shares of Aveanna common stock under Rule 144. The proposed sale, to be executed through Morgan Stanley Smith Barney LLC, has an approximate aggregate market value of $3,224,802.00 and references Aveanna common shares outstanding of 218,219,696. The shares derive from multiple restricted stock awards granted between January 2023 and February 2025.
Aveanna Healthcare Holdings, Inc. (AVAH) had a major shareholder, J.H. Whitney Equity Partners VII, LLC, report significant sales of common stock through affiliated entities. On August 20–21, 2026, entities associated with this reporting person sold a total of 14,746,077 shares of common stock at $11.50 per share in an underwritten secondary offering, including sales by J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC. After these transactions, J.H. Whitney VII, L.P. and PSA Iliad Holdings LLC reported 0 shares held, the reporting person reported no direct holdings, and the filing states that the reporting person and certain affiliates disclaim beneficial ownership except to the extent of their pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) reported that entities associated with reporting person Robert M. Williams, Jr., a ten percent owner, executed a series of indirect sales of 16,750,002 shares of common stock at $11.50 per share on August 20–21, 2026. According to the footnotes, J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings, LLC, JHW Iliad Holdings II, LLC and PSA Iliad Holdings LLC sold these shares in an underwritten secondary offering, including sales pursuant to an option to purchase additional shares. Williams is described as associated with the managing or controlling entities of these stockholder entities and disclaims beneficial ownership of the securities except to the extent of his pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) reports that entities associated with reporting person Paul R. Vigano sold an aggregate of 16,750,002 shares of common stock in underwritten secondary offerings at $11.50 per share on August 20–21, 2026. The sales were made indirectly through several investment and holding entities, and Vigano disclaims beneficial ownership except to the extent of his pecuniary interest.
Aveanna Healthcare Holdings, Inc. (AVAH) director Rodney D. Windley reported selling 180,000 shares of common stock on August 20, 2026 at $11.50 per share. The sale was part of a 15,000,000‑share secondary offering of Aveanna common stock that closed on August 24, 2026, and left him holding 2,078,017 shares directly.
Aveanna Healthcare Holdings, Inc. (AVAH) reported that Chief Executive Officer Jeff Shaner sold 90,000 shares of common stock on August 20, 2026 at $11.50 per share, as part of an underwritten secondary offering of 15,000,000 shares. Following this sale, he directly holds 2,561,972 shares, which include 1,080 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.
Aveanna Healthcare Holdings, Inc. (AVAH) reports that Chief Administrative Officer Edwin C. Reisz sold 50,000 shares of common stock on August 20, 2026 at $11.50 per share. The shares were sold as part of an underwritten secondary offering of 15,000,000 shares of Aveanna common stock that closed on August 24, 2026. After this sale, Reisz beneficially holds 1,397,897 shares, which includes 840 shares acquired under the company’s Employee Stock Purchase Plan in June 2026.
Aveanna Healthcare Holdings, Inc. (AVAH) reports that certain existing stockholders completed a secondary public offering of its common stock. On August 20, 2026, the company and the selling stockholders entered into an Underwriting Agreement with RBC Capital Markets, LLC for the sale by those stockholders of 15,000,000 shares of Aveanna common stock at a public offering price of $11.75 per share. The selling stockholders also granted the underwriter a 30‑day option to purchase up to an additional 2,250,000 shares. The secondary offering closed on August 24, 2026. Aveanna did not issue any new shares and did not receive any proceeds from this offering; all proceeds went to the selling stockholders.
Aveanna Healthcare Holdings Inc. (AVAH) has filed a prospectus supplement for the resale by selling stockholders of 15,000,000 shares of common stock at a public offering price of $11.75 per share. Aveanna will not receive any proceeds from this secondary offering, though it will bear offering expenses other than underwriting discounts and commissions.
The selling stockholders will receive net proceeds of $11.50 per share, or $172.5 million in total, with RBC Capital Markets acting as sole underwriter and holding a 30‑day option to purchase up to 2,250,000 additional shares. Aveanna had 218,152,927 shares outstanding as of July 4, 2026. After completion, the company will no longer be a Nasdaq-defined controlled company, though Bain Capital and J.H. Whitney affiliates are expected to retain significant influence with beneficial ownership of about 44.1% of common stock. Aveanna recently expanded its Private Duty Services segment by acquiring Family First Holding, LLC, a multi-state pediatric home care provider with 27 locations in seven states.
Aveanna Healthcare Holdings Inc. (AVAH) has registered a resale offering of 15,000,000 shares of common stock, all to be sold by existing selling stockholders; Aveanna will not receive any proceeds from these sales but will pay offering expenses other than underwriting discounts and commissions.
The underwriter has a 30‑day option to purchase up to 2,250,000 additional shares from certain Whitney-affiliated stockholders. Aveanna had 218,152,927 shares outstanding as of July 4, 202644.1% of the common stock and retain significant influence.